AstraZeneca PLC announces that, on 14 August 2018, it priced a four tranche global bond offering totalling $3bn. The offering is expected to close on 17 August 2018, subject to customary closing conditions. AstraZeneca expects to use the net proceeds of the issue for general corporate purposes, which may include the refinancing of existing indebtedness…